検索結果

Business Activities | About Senju | SENJU Pharmaceutical

e have always taken a pioneering path in ophthalmic pharmaceuticals. In the hope of developing even more original new products for the future, we have begun to take on the challenge of the five senses...

論文投稿実績 | 研究開発活動 | 千寿製薬株式会社

jima, R.D. Walkup, D.J. Wilson, T.R. Shearer and M. Azuma Histol Histopathol (2024) 39: 165-175 See more

お知らせ | 千寿製薬株式会社

f “MIEr for NAVIS”（PDF） November 1, 2023 Launch of Distribution of the OptiLight M22 IPL Model（PDF） More

fficacy of the previous formulation while eliminating BAC to avoid such damage and ensure safer and more reliable use. For this approval, a bioequivalence study was conducted on patients with primary ...

fficacy of the previous formulation while eliminating BAC to avoid such damage and ensure safer and more reliable use. For this approval, a bioequivalence study was conducted on patients with primary ...